Amide-based derivatives of β-alanine hydroxamic acid as histone deacetylase inhibitors: attenuation of potency through resonance effects.

A library of amide-linked derivatives of β-alanine hydroxamic acid were prepared (2-7) and the activity as inhibitors of Zn(II)-containing histone deacetylases (HDACs) determined in vitro against HDAC1 and the anti-proliferative activity determined in BE(2)-C neuroblastoma cells. The IC(50) values of the best-performing compounds (3-7) against HDAC1 ranged between 38 and 84μM. The least potent compound (2) inhibited a maximum of only 40% HDAC1 activity at 250μM. The anti-proliferative activity of 2-7 at 50μM against BE(2)-C neuroblastoma cells ranged between 57.0% and 88.6%. The structural similarity between the potent HDAC inhibitor trichostatin A (TSA, 1; HDAC1, IC(50) 12nM) and the present compounds (2-7) was high at the Zn(II) coordinating hydroxamic acid head group; and in selected compounds (2, 5), at the 4-(dimethylamino)phenyl tail. The significantly reduced potency of 2-7 relative to 1 underscores the rank importance of the linker region as part of the HDAC inhibitor pharmacophore. Molecular modeling of 1-7 using HDAC8 as the template suggested that the conformationally constrained 4'-methyl group of 1 may contribute to HDAC inhibitor potency through a sandwich-like interaction with a hydrophobic region containing F152 and F208; and that the absence of this group in 2-7 may reduce potency. The close proximity of the 5'-carbonyl oxygen atom in 2-7 to the sulfur atom of Met274 in HDAC8 or the corresponding isobutyl group of Leu274 in HDAC1 may attenuate potency through repulsive steric and dipole-dipole forces. In a unique resonance stabilized form of 2, this interaction could manifest as stronger ion-dipole repulsive forces, resulting in a further decrease in potency. This work suggests that resonance structures of HDAC inhibitors could modulate intermolecular interactions with HDAC targets, and potency.

• Publication year

  2012

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2012-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2012.08.006PMID 22932316
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analytical-scale purification of trichostatin A from bacterial culture in a single step and with high selectivity using immobilised metal affinity chromatography

  2012cited by this paper
• Rational development of a strategy for modifying the aggregatibility of proteins

  2011cited by this paper
• SIRT1 Promotes N-Myc Oncogenesis through a Positive Feedback Loop Involving the Effects of MKP3 and ERK on N-Myc Protein Stability

  2011cited by this paper
• Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors.

  2011cited by this paper
• Inside HDAC with HDAC inhibitors.

  2010cited by this paper
• Synthesis and structure-activity relationship of dicationic diaryl ethers as novel potent anti-MRSA and anti-VRE agents.

  2009cited by this paper
• Zn(II)-dependent histone deacetylase inhibitors: suberoylanilide hydroxamic acid and trichostatin A.

  2009cited by this paper
• Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors.

  2008cited by this paper
• Traversing the coordination chemistry and chemical biology of hydroxamic acids

  2008cited by this paper
• Human HDAC7 Harbors a Class IIa Histone Deacetylase-specific Zinc Binding Motif and Cryptic Deacetylase Activity*

  2008cited by this paper
• Structural studies of human histone deacetylase 8 and its site-specific variants complexed with substrate and inhibitors.

  2008cited by this paper
• Histone deacetylase inhibitors: multifunctional anticancer agents.

  2006cited by this paper
• Anticancer activities of histone deacetylase inhibitors

  2006cited by this paper
• Efficient, enantioselective organocatalytic synthesis of trichostatin A

  2006cited by this paper
• Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases.

  2004cited by this paper
• Thiol-based SAHA analogues as potent histone deacetylase inhibitors.

  2004cited by this paper
• Hydroxamic Acids − An Intriguing Family of Enzyme Inhibitors and Biomedical Ligands

  2004cited by this paper
• Histone deacetylase inhibitors.

  2003cited by this paper
• Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors

  1999cited by this paper
• Amide analogues of trichostatin A as inhibitors of histone deacetylase and inducers of terminal cell differentiation.

  1999cited by this paper
• A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.

  1998cited by this paper
• Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is?

  1998cited by this paper
• van der Waals Volumes and Radii

  1964cited by this paper

• The influence of the isocyanoesters structure on the course of enzymatic Ugi reactions.

  2019cites this paper
• Recent Perspectives of Anticancer Histone Deacetylase Inhibitors

  2019cites this paper
• Reverse Biosynthesis: Generating Combinatorial Pools of Drug Leads from Enzyme‐Mediated Fragmentation of Natural Products

  2017cites this paper
• High-performance liquid chromatographic enantioseparation of cyclic β-aminohydroxamic acids on zwitterionic chiral stationary phases based on Cinchona alkaloids.

  2016cites this paper
• From Amino Acids to High-Energy Dense Oxidizers: Polynitro Materials Derived from beta-Alanine and L-Aspartic Acid

  2016cites this paper
• New Applications of Immobilized Metal Ion Affinity Chromatography in Chemical Biology

  2014cites this paper